Soda and processed-food makers insist that all sugars are the same. Yet with studies linking fructose to obesity, diabetes and, most recently, pancreatic cancer, big brands are quietly backing away from using corn-based high-fructose sweetener. Could it eventually become another tobacco-like liability?
Roche's blockbuster cancer drug, Avastin, could lose its U.S. Food and Drug Administration approval for use against breast cancer after an FDA panel recommended the withdrawal. Studies failed to show the drug extends breast-cancer patients' lives, panelists say.
In an effort to reduce smoking, governments worldwide are raising their tobacco taxes: In New York City, a pack of cigarettes now costs more than $10. But do higher taxes, which mean higher prices, actually deter smokers?
Some of the best reads for investors from around the Web, including posts about why the Standard & Poor's 500 is on its way up, why Warren Buffett's bullish on Tesco, why drug company Dendreon fell 20% in after-hours trading, and why a hamburger is called a hamburger.
A marijuana-based prescription drug for multiple sclerosis, Sativex, hit U.K. pharmacies Monday after winning regulator approval Friday. In light of the new approval, are arguments against medical marijuana half-baked?
Angiotensin-receptor blockers, a common class of blood pressure medications, have been linked to an increased risk of cancer in a recent study. These widely used drugs include medicines such as Boehringer's Micardis, Merck's Cozaar and Hyzaar, and Novartis's Diovan.
Micromet shares traded some 3.3% higher on Monday after the small-cap biotech announced that its candidate drug blinatumomab led to remission in almost four-fifths of leukemia patients in a Phase II trial. It also said that a Phase I trial showed the drug induced durable remission in patients with non-Hodgkin lymphoma.
Some of the best reads for investors from around the Web, including bullishness from Goldman Sachs and forecasters, intriguing small-cap stocks and a video of Treasury Secretary Tim Geithner playing basketball.
"The American people -- even before they are born -- are bombarded continually with myriad combinations of these dangerous exposures," the President's Cancer Panel says. And that means more spending on prevention in addition to treatment.
Resveratrol, a substance found in red wine, could slow age-related disease and extend patients' life spans. But GlaxoSmithKline has suspended a trial of a resveratrol drug as a result of safety concerns.
